Location History:
- Frederick, MD (US) (2009)
- Germantown, MD (US) (2015)
Company Filing History:
Years Active: 2009-2015
Title: The Innovative Contributions of Kara E Schmid
Introduction
Kara E Schmid is a notable inventor based in Germantown, MD (US). She has made significant contributions to the field of biomedical research, particularly in the development of methods and devices that have implications for both animal testing and human health.
Latest Patents
Kara E Schmid holds 2 patents, showcasing her innovative approach to complex scientific challenges. Her latest patents include a "Device and method for inducing brain injury in animal test subjects," which describes an apparatus designed to inflict brain injury on laboratory animals. This device employs a platform that supports the animal while allowing for a projectile to be launched, resulting in either a pressure wave or concussive impact. The invention aims to study traumatic brain injuries and the protective effects of helmets on such injuries. Another significant patent is for "Recombinant chimeric human anti-botulinum antibodies," which details the production of humanized antibodies that are specific for both BoNt/A and BoNT/B. These antibodies are crucial for detecting human exposure to botulinum toxins.
Career Highlights
Throughout her career, Kara has worked with esteemed organizations, including the U.S. Government as represented by the Secretary of the Army and the U.S. Government as represented by the Secretary of the Navy. Her work in these institutions has allowed her to contribute to important research initiatives that have far-reaching implications.
Collaborations
Kara has collaborated with notable colleagues such as Zhiyong Chen and Zhilin Liao. These partnerships have enhanced her research and innovation efforts, leading to advancements in her field.
Conclusion
Kara E Schmid's contributions to the field of biomedical research through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the understanding of brain injuries and the development of therapeutic antibodies.